SCHOTT
Emballages pharmaceutiques primaires (français)
change
Submission Details
Country Of Submission*
- Please select -
USA (FDA)
Canada (Health Canada)
China (NMPA)
Are you working for a third party customer?
We offer our customers the alternative to submit individual request upon third parties Letter of Authorization (LoA) application in China. Please kindly direct your request to Dr. Karen Liu (
Karen.liu@schott.com
)
Company requesting to issue a LOA
Company Name*
Company Name China
(In China, only relevant to China submission. If there is no
corresponding Chinese translation of your Company Name
or there is no Company Name in Chinese, please use your
English Company Name)
*
Address 1
(Please provide Postal address in English)*
Address 2
Ville*
State/Province*
Zip/Postal Code*
Pays*
Sélectionnez un pays
Afrique du Sud
Albanie
Algérie
Allemagne
Arabie Saoudite
Argentine
Australie
Autriche
Bangladesh
Belgique
BeNeLux
Bosnie-Herzégovine
Brésil
Bulgarie
Bélarus
Canada
Chine
Chypre
Colombie
Croatie
Danemark
Espagne
Estonie
Finlande
France
Fédération de Russie
Grèce
Hong-Kong
Hongrie
Inde
Indonésie
Irlande
Israël
Italie
Japon
Lettonie
Libye
Lituanie
Luxembourg
Macédoine
Malaisie
Maroc
Mexique
Monténégro
Myanmar, Birmanie
Norvège
Nouvelle-Zélande
Pakistan
Pays-Bas
Philippines
Pologne
Portugal
Pérou
Roumanie
Royaume-Uni
République de Corée
République Islamique d’ Iran
République Tchèque
Serbie
Singapour
Slovaquie
Slovénie
Suisse
Suède
Syrienne
Taïwan
Tunisie
Turquie
Ukraine
Venezuela
Viêt Nam
Yémen
Égypte
Émirats Arabes Unis
Équateur
États-Unis
First Name*
Last Name*
Title
Tél.*
E-mail*
E-Mail Confirmation
Company for whom the LOA is being issued
Is the company for whom the LOA is being issued the same as the requesting company?
If not, please add additional company by clicking the button below.
Add Additional Company
Issue LOA for the following company:
Company Name*
Company Name
(in Chinese, only relevant for China Submission)
Address 1*
Address 2
Ville*
State/Province*
Zip/Postal Code*
Pays*
Sélectionnez un pays
Afrique du Sud
Albanie
Algérie
Allemagne
Arabie Saoudite
Argentine
Australie
Autriche
Bangladesh
Belgique
BeNeLux
Bosnie-Herzégovine
Brésil
Bulgarie
Bélarus
Canada
Chine
Chypre
Colombie
Croatie
Danemark
Espagne
Estonie
Finlande
France
Fédération de Russie
Grèce
Hong-Kong
Hongrie
Inde
Indonésie
Irlande
Israël
Italie
Japon
Lettonie
Libye
Lituanie
Luxembourg
Macédoine
Malaisie
Maroc
Mexique
Monténégro
Myanmar, Birmanie
Norvège
Nouvelle-Zélande
Pakistan
Pays-Bas
Philippines
Pologne
Portugal
Pérou
Roumanie
Royaume-Uni
République de Corée
République Islamique d’ Iran
République Tchèque
Serbie
Singapour
Slovaquie
Slovénie
Suisse
Suède
Syrienne
Taïwan
Tunisie
Turquie
Ukraine
Venezuela
Viêt Nam
Yémen
Égypte
Émirats Arabes Unis
Équateur
États-Unis
First Name*
Last Name*
Title
Tél.*
E-mail*
SCHOTT Product Details
SCHOTT Product Manufacturing Facility*
- Please select -
SCHOTT AG, Germany
SCHOTT Brasil Ltda., Brazil
SCHOTT Envases Argentina S.A., Argentina
SCHOTT Envases Farmacéuticos S.A., Colombia
SCHOTT de México, S.A. de C.V., Mexico
SCHOTT France Pharma Systems SAS, France
SCHOTT Glass Technologies (Suzhou) Co., Ltd., China
SCHOTT Pharmaceutical Packaging (Zhejiang) Co., Ltd., China
SCHOTT Hungary Kft., Hungary
PT. SCHOTT Igar Glass, Indonesia
SCHOTT North America, Inc., USA
LLC. SCHOTT PHARMACEUTICAL PACKAGING, Russia
SCHOTT Schweiz AG, Switzerland
SCHOTT Product Group*
- Please select -
Ampoule
Ampoule Brown
Cartridge
Syringe (Glass)
Syringe (Polymer)
Vial (Glass)
Vial (adaptiQ®)
Vial (Boro 8330TM)
Vial (Glass, Brown)
Vial (Polydimethylsiloxane Film)
Vial (illax Glass, Polydimethylsiloxane Film)
Vial (illax Glass)
Coated Vial (Type I plus®)
Coated Vial (TopLyO®)
Syringe (Glass Barrel)
SCHOTT Product Description (e.g. pen cartridge 20ml)*
SCHOTT Article No. (7-digit starting with 1... )
specification/model*
(Please kindly enter the format or
size of the container(s) used, e.g. 2 mL)
Information of Drug to be applied at the NMPA in China (China Submission),
(Should be identical to the name given in the submission dossier to NMPA)
Name of the drug (in English)*
Name of the drug (in Chinese)*
(If there is no corresponding Chinese translation or Chinese Name
of the Drug, please enter Name of the Drug in English into this
field)
Route of administration (in English)*
Route of administration (in Chinese)*
Comments
Comments
Please enter the numer of originals of the
requested China LoA
; if no hard copy is needed,
please enter ’No original/hard copy is required’
in this field.*
* = champ obligatoire